Medtronic (MDT) Other Accumulated Expenses (2014 - 2026)

Medtronic (MDT) has 13 years of Other Accumulated Expenses data on file, last reported at $3.6 billion in Q2 2026.

• For the quarter ending Q2 2026, Other Accumulated Expenses fell 1.33% year-over-year to $3.6 billion; the trailing twelve-month figure through Apr 2026 stood at $3.6 billion (down 1.33% YoY), and the FY2026 full-year result was $3.6 billion, down 1.33% from the prior year.
• Other Accumulated Expenses rose to $3.6 billion in Q2 2026, from $3.5 billion in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $4.0 billion in Q4 2022 to a low of $3.2 billion in Q4 2025.
• A 5-year average of $3.6 billion and a median of $3.6 billion in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses advanced 16.2% in 2022 and decreased 18.16% in 2023, its largest moves.
• Tracing MDT's Other Accumulated Expenses over 5 years: stood at $4.0 billion in 2022, then dropped by 18.16% to $3.3 billion in 2023, then declined by 1.18% to $3.3 billion in 2024, then decreased by 3.28% to $3.2 billion in 2025, then gained by 15.26% to $3.6 billion in 2026.
• Business Quant data shows MDT's Other Accumulated Expenses at $3.6 billion in Q2 2026, $3.5 billion in Q1 2026, and $3.2 billion in Q4 2025.